Matador能源 MTDR 深 沪
等待开盘 04-02 09:30:00 美东时间
60.66
-2.520
-3.99%
华盛通- 最 高62.595
- 今 开61.49
- 成交量 229.83万股
- 最 低 59.85
- 昨 收 63.18
- 总市值 75.37亿
- 52周最高 66.8387
- 市盈率 静 9.95
- 换手率 1.85%
- 52周最低 36.39
- 委 比 -26.09%
- 总股本 1.24亿
- 历史最高 70.4925
- 量 比 1.08
- 振 幅 4.34%
- 历史最低 -2.5025
- 每 手 1
- 风险率 5.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 存储分歧大！花旗大砍17%将美光目标价从510降至425美元；Bernstein上调希捷科技目标价从500升至620美元
今日重点评级关注：Maxim Group：上调Theriva Biologics评级至"买入"，目标价1美元；HC Wainwright & Co.：维持Bicara Therapeutics"买入"评级，目标价从40美元升至42美元
04-01 16:34
Citigroup Maintains Buy on Matador Resources, Raises Price Target to $77
Citigroup analyst Paul Diamond maintains Matador Resources (NYSE:MTDR) with a Buy and raises the price target from $62 to $77.
04-01 03:47
U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources
U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources March 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, Diamondback Energy and Matador Resources on Wednesday. HIGHLIGHTS * Amazon AMZN.O : JP
03-25 16:01
美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
新浪财经ESG：Matador Resources MSCI（明晟）ESG评级调升至BBB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:25
Brent Hits $110, Rate-Hike Fears Hammer Stocks And Gold: What's Moving Markets Friday?
U.S. stocks fall to four-month lows as oil surges above $110, Treasury yields spike, and markets price a 50% chance of a Fed rate hike by October.
03-21 01:36
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson
U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson March 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biogen, Eli Lilly and Johnson & Johnson on Tuesday. HIGHLIGHTS * Biogen BIIB.O : HSBC raises target pri
03-17 15:31
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Wells Fargo Maintains Equal-Weight on Matador Resources, Raises Price Target to $54
Wells Fargo analyst Hanwen Chang maintains Matador Resources (NYSE:MTDR) with a Equal-Weight and raises the price target from $47 to $54.
03-16 22:16
